The SWI/SNF complex - Chromatin and cancer

Nature Reviews Cancer

Volumn 4, Issue 2, 2004, Pages 133-142

  Roberts, Charles W M ^a   Orkin, Stuart H ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; PROTEIN SNF P; PROTEIN SUBUNIT; PROTEIN SWI; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CANCER; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CHROMATIN; CHROMATIN STRUCTURE; COMPLEX FORMATION; GENE INACTIVATION; GENETIC CONSERVATION; HUMAN; HYDROLYSIS; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 1042290351     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1273     Document Type: Review

References (78)

1. Neely, K. E. & Workman, J. L. Histone acetylation and chromatin remodeling: which comes first? Mol. Genet. Metab. 76, 1-5 (2002).
2. Geiman, T. M. & Robertson, K. D. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together? J. Cell. Biochem. 87, 117-125 (2002).
3. Caims, B. R. Emerging roles for chromatin remodeling in cancer biology. Trends Cell Biol. 11, S15-S21 (2001).
4. Winston, F. & Carlson, M. Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet. 8, 387-391 (1992).
5. Sudarsanam, P., Iyer, V. R., Brown, P. O. & Winston, F. Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 97, 3364-3369 (2000). Microarray analysis of yeast mutants demonstrating that SWI/SNF controls transcription at specific loci, has differential effects in rich versus minimal media, and acts to both repress and activate transcription of 5% of yeast genes.
6. Holstege, F. C. et al. Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95, 717-728 (1998).
7. Hirschhorn, J. N., Brown, S. A., Clark, C. D. & Winston, F. Evidence that SNF2/SWI2 and SNF5 activate transcription in yeast by altering chromatin structure. Genes Dev. 6, 2288-2298 (1992).
8. Phelan, M. L., Sif, S., Narlikar, G. J. & Kingston, R. E. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol. Cell 3, 247-253 (1999). Defines the functional core of human SWI/SNF by showing that SNF5, BAF155, BAF170 and either BRG1 or BRM have in vitro remodelling activity equal to the whole complex.
9. Schnitzler, G. R., Sif, S. & Kingston, R. E. A model for chromatin remodeling by the SWI/SNF family. Cold Spring Harb. Symp. Quant. Biol. 63, 535-543 (1998).
10. Schnitzler, G., Sif, S. & Kingston, R. E. Human SWI/SNF interconverts a nucleosome between its base state and a stable remodeled state. Cell 94, 17-27 (1998). Demonstrates that SWI/SNF acts by facilitating an exchange between normal and altered, more accessible, nucleosome conformations.
11. Kassabov, S. R., Zhang, B., Persinger, J. & Bartholomew, B. SWI/SNF unwraps, slides, and rewraps the nucleosome. Mol. Cell 11, 391-403 (2003).
12. Vignali, M., Hassan, A. H., Neely, K. E. & Workman, J. L. ATP-dependent chromatin-remodeling complexes. Mol. Cell. Biol. 20, 1899-1910 (2000).
13. Wang, W. The SWI/SNF family of ATP-dependent chromatin remodelers: similar mechanisms for diverse functions. Curr. Top. Microbiol. Immunol. 274, 143-169 (2003).
14. Flanagan, J. F. & Peterson, C. L. A role for the yeast SWI/SNF complex in DNA replication. Nucleic Acids Res. 27, 2022-2028 (1999).
15. Lee, D., Sohn, H., Kalpana, G. V. & Choe, J. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 399, 487-491 (1999).
16. Yung, E. et al. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nature Med. 7, 920-926 (2001).
17. Kalpana, G. V., Marmon, S., Wang, W., Crabtree, G. R. & Goff, S. P. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266, 2002-2006 (1994).
18. Krebs, J. E., Fry, C. J., Samuels, M. L. & Peterson, C. L. Global role for chromatin remodeling enzymes in mitotic gene expression. Cell 102, 587-598 (2000).
19. Biegel, J. A. et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59, 74-79 (1999).
20. Sevenet, N. et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am. J. Hum. Genet. 65, 1342-1348 (1999).
21. Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203-206 (1998).
22. Rorke, L. B., Packer, R. & Biegel, J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J. Neurooncol. 24, 21-28 (1995).
23. Biegel, J. A. et al. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes Chromosomes Cancer 28, 31-37 (2000).
24. Savla, J. et al. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J. Natl Cancer Inst. 92, 648-650 (2000).
25. Taylor, M. D. et al. Famillal posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am. J. Hum. Genet. 66, 1403-1406 (2000).
26. Sevenet, N. et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum. Mol. Genet. 8, 2359-2368 (1999).
27. Weber, M., Stockhammer, F., Schmitz, U. & von Deimling, A. Mutational analysis of INI1 in sporadic human brain tumors. Acta Neuropathol. 101, 479-482 (2001).
28. Gessi, M., Giangaspero, F. & Pietsch, T. Atypical teratoid/rhabdoid tumors and choroid plexus tumors: when genetics 'surprise' pathology. Brain Pathol. 13, 409-414 (2003).
29. Schmitz, U. et al. INI1 mutations in meningiomas at a potential hotspot in exon 9. Br. J. Cancer 84, 199-201 (2001).
30. Biegel, J. A. et al. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin. Cancer Res. 6, 2759-2763 (2000).
31. Uno, K. et al. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Genes Chromosom. Cancer 84, 33-41 (2002).
32. Haas, J. E., Palmer, N. F., Weinberg, A. G. & Beckwith, J. B. Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum. Pathol. 12, 646-657 (1981).
33. Roberts, C. W., Galusha, S. A., McMenamin, M. E., Fletcher, C. D. & Orkin, S. H. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc. Natl Acad. Sci. USA 97, 13796-13800 (2000).
34. Klochendler-Yeivin, A. et al. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 1, 500-506 (2000).
35. Guidi, C. J. et al. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol. Cell. Biol. 21, 3598-3603 (2001).
36. Roberts, C. W., Leroux, M. M., Fleming, M. D. & Orkin, S. H. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2, 415-425 (2002).
37. Art predisposes mice to tumorigenesis. Nature 413, 86-91 (2001).
38. Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
39. Versteege, I., Medjkane, S., Rouillard, D. & Delattre, O. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene 21, 6403-6412 (2002).
40. Ink4a and activation of RB. Oncogene 21, 5193-5203 (2002).
41. INK4a is required for hSNF5 chromatin-remodeler induced cellular senescence in malignant rhabdoid tumor cells. J. Biol. Chem. (2003).
42. Laurent, B. C., Treich, I. & Carlson, M. The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. Genes Dev. 7, 583-591 (1993).
43. Dingwall, A. K. et al. The Drosophila snr1 and brm proteins are related to yeast SWI/SNF proteins and are components of a large protein complex. Mol. Biol. Cell 6, 777-791 (1995).
44. Elfring, L. K., Deuring, R., McCallum, C. M., Peterson, C. L. & Tamkun, J. W. Identification and characterization of Drosophila relatives of the yeast transcriptional activator SNF2/SWI2. Mol. Cell. Biol. 14, 2225-2234 (1994).
45. Randazzo, F. M., Khavari, P., Crabtree, G., Tamkun, J. & Rossant, J. brg1: a putative murine homologue of the Drosophila brahma gene, a homeotic gene regulator. Dev. Biol. 161, 229-242 (1994).
46. Muchardt, C. & Yaniv, M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 12, 4279-4290 (1993).
47. Khavari, P. A., Peterson, C. L., Tamkun, J. W., Mendel, D. B. & Crabtree, G. R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366, 170-174 (1993).
48. Chiba, H., Muramatsu, M., Nomoto, A. & Kato, H. Two human homologues of Saccharomyces carevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res. 22, 1815-1820 (1994).
49. Decristofaro, M. F. et al. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J. Cell. Physiol. 186, 136-145 (2001).
50. Wong, A. K. et al. BRG1, component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res. 60, 6171-6177 (2000).
51. Reisman, D. N., Sciarrotta, J., Wang, W., Funkhouser, W. K. & Weissman, B. E. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res. 63, 560-566 (2003).
52. Bultman, S. et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 6, 1287-1295 (2000). This study shows that inactivation of Brg1 in mice is embryonic lethal and that haploinsufficiency predisposes to a low rate of tumour formation.
53. Reyes, J. C. et al. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2α). EMBO J. 17, 6979-6991 (1998). This study demonstrates that Brm is not required for survival of mice, but that its loss causes increased cell proliferation, decreased cell-cycle arrest and results in heavier animals.
54. Dunaief, J. L. et al. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79, 119-130 (1994). A key report demonstrating physical and functional cooperation between RB and the SWI/SNF complex.
55. Strobeck, M. W. et al. BRG-1 is required for RB-mediated cell cycle arrest. Proc. Natl Acad. Sci. USA 97, 7748-7753 (2000).
56. Zhang, H. S. et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79-89 (2000).
57. Trouche, D., Le Chalony, C., Muchardt, C., Yaniv, M. & Kouzarides, T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc. Natl Acad. Sci. USA 94, 11268-11273 (1997).
58. Lee, E. Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 289-294 (1992).
59. Bochar, D.A. et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102, 257-265 (2000). This paper demonstrated that BRCA1 directly interacts with BRG1 and that BRCA1-dependent transcription is abrogated by a dominant-negative form of BRG1.
60. D'Andrea, A. D. & Grompe, M. The Fanconi anaemia/BRCA pathway. Nature Rev. Cancer 3, 23-34 (2003).
61. Park, J., Wood, M. A. & Cole, M. D. BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation. Mol. Cell. Biol 22, 1307-1316 (2002).
62. Cheng, S. W. et al. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nature Genet. 22, 102-105 (1999). An important paper demonstrating that SNF5 directly binds to c-MYC and is necessary for its transactivating activity.
63. Amati, B., Frank, S. R., Donjerkovic, D. & Taubert, S. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta 1471, M135-M145 (2001).
64. Takayama, M. A., Taira, T., Tamai, K., Iguchi-Ariga, S. M. & Ariga, H. ORC1 interacts with c-Myc to inihibit E-box-dependent transcription by abrogating c-Myc-SNF5/INI1 interaction. Genes Cells 5, 481-490 (2000).
65. Rozenblatt-Rosen, O. et al. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc. Natl Acad. Sci. USA 95, 4152-4157 (1998).
66. Nie, Z. et al. Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol. Cell. Biol. 23, 2942-2452 (2003).
67. Debemardi, S. et al. The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 99, 275-281 (2002).
68. Adler, H. T. et al. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol. Cell. Biol. 19, 7050-7060 (1999).
69. Nakamura, T. et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 10, 1119-1128 (2002).
70. Murphy, D. J., Hardy, S. & Engel, D. A. Human SWI-SNF component BRG1 represses transcription of the c-fos gene. Mol. Cell. Biol. 19, 2724-2733 (1999).
71. Lee, D. et al. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J. Biol. Chem. 11, 11 (2002).
72. Barker, N. et al. The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation. EMBO J. 20, 4935-4943 (2001).
73. Kadam, S. & Emerson, B. M. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol. Cell 11, 377-389 (2003).
74. Strobeck, M. W. et al. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J. Biol. Chem. 276, 9273-9278 (2001).
75. Look, A. T. Oncogenic role of 'master' transcription factors in human leukemias and sarcomas: a developmental model. Adv. Cancer Res. 67, 25-57 (1995).
76. Kadam, S. et al. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev. 14, 2441-2451 (2000). Shows that specific domains of certain transcription factors differentially target SWI/SNF complexes to chromatin in a gene-selective manner and that individual SWI/SNF subunits have unique roles in transcription-factor-directed nucleosome remodelling.
77. Klochendler-Yeivin, A., Muchardt, C. & Yaniv, M. SWI/SNF chromatin remodeling and cancer. Curr. Opin. Genet. Dev. 12, 73-79 (2002).
78. Sudarsanam, P. & Winston, F. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet 16, 345-351 (2000).